The impact of extra-fine inhalation corticosteroid particles on small-airway disease in Chronic Obstructive Pulmonary Disease (COPD): a randomized, prospective cross-over trial.
Approved other active
Quick answer
The impact of extra-fine inhalation corticosteroid particles on small-airway disease in Chronic Obstructive Pulmonary Disease (COPD): a randomized, prospective cross-over trial. for Chronic Obstructive Pulmonary Disease is a Approved program (other) at Pierre Fabre Médicament with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pierre Fabre Médicament
- Indication
- Chronic Obstructive Pulmonary Disease
- Phase
- Approved
- Modality
- other
- Status
- active